Arvinas Inc (ARVN)
24.80
-1.18
(-4.54%)
USD |
NASDAQ |
Jul 02, 16:00
24.65
-0.15
(-0.60%)
After-Hours: 20:00
Arvinas Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 15.70M |
| June 30, 2023 | 0.10M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 1.00M |
| September 30, 2022 | 1.00M |
| June 30, 2022 | 1.40M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 15.00M |
| September 30, 2021 | 1.880M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 1.00M |
| September 30, 2020 | 2.444M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0593M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 2.776M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 25.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
15.70M
Maximum
Sep 2023
2.474M
Average
0.55M
Median
Accounts Receivable (Quarterly) Benchmarks
| Pfizer Inc | 10.99B |
| BridgeBio Pharma Inc | -- |
| Alnylam Pharmaceuticals Inc | 321.38M |
| Agios Pharmaceuticals Inc | 3.453M |
| Krystal Biotech Inc | 46.47M |